Brookfield Renewable Partners LP
BEP.UN
The Toronto-Dominion Bank
TD
BCE Inc
BCE
TC Energy Corp
TRP
Enbridge Inc
ENB
(Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | (Q1)Aug 31, 2023 | (FY)May 31, 2023 | (Q4)May 31, 2023 | (Q3)Feb 28, 2023 | (Q2)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 696.97%394M | 27.19%7.43B | 16.25%2.62B | -7.67%2.06B | 181.42%2.82B | -118.49%-66M | 12.59%5.84B | 95.74%2.25B | 1,219.53%2.23B | -63.69%1B |
Net income from continuing operations | -27.52%1.05B | 12.43%5.7B | 45.49%1.5B | -5.48%1.17B | 18.56%1.58B | -1.23%1.45B | -16.14%5.07B | -28.35%1.03B | -11.17%1.24B | -0.45%1.33B |
Operating gains losses | 0.00%-7M | 35.21%-138M | -256.25%-57M | 47.22%-38M | 74.47%-36M | -143.75%-7M | -719.23%-213M | 44.83%-16M | -60.00%-72M | -2,920.00%-141M |
Depreciation and amortization | -1.08%184M | -1.75%844M | -13.56%204M | 87.50%270M | -42.32%184M | 16.25%186M | 2.26%859M | -20.27%236M | -21.31%144M | 65.28%319M |
Remuneration paid in stock | -6.63%183M | 6.49%804M | -6.53%186M | 12.50%216M | 6.19%206M | 15.29%196M | 18.34%755M | 16.37%199M | 19.25%192M | 14.12%194M |
Deferred tax | 22.06%-53M | -324.79%-497M | -318.18%-216M | -107.58%-137M | 28.97%-76M | -58.14%-68M | 82.00%-117M | 123.80%99M | -450.00%-66M | -38.96%-107M |
Change In working capital | 47.12%-964M | 239.57%716M | 42.33%1B | -27.27%576M | 261.51%961M | -28.93%-1.82B | 69.10%-513M | 327.10%704M | 152.31%792M | -152.70%-595M |
-Change in receivables | 49.76%-312M | -167.28%-329M | -73.68%100M | -77.71%220M | 93.95%-28M | -49.64%-621M | 197.02%489M | 139.18%380M | 1,381.82%987M | -191.32%-463M |
-Change in inventory | -158.17%-679M | 782.71%908M | -46.70%210M | -51.31%205M | 82.17%756M | 80.70%-263M | 92.06%-133M | 149.00%394M | 136.93%421M | 148.50%415M |
-Change in prepaid assets | -17.78%-265M | 59.63%-260M | 122.10%82M | 252.94%52M | -52.25%-169M | -75.78%-225M | 23.79%-644M | -80.10%-371M | 82.56%-34M | 45.05%-111M |
-Change in payables and accrued expense | 140.90%292M | 276.44%397M | 102.66%610M | 117.01%99M | 192.20%402M | -245.12%-714M | -116.48%-225M | -81.98%301M | -470.59%-582M | -166.36%-436M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 696.97%394M | 27.19%7.43B | 16.25%2.62B | -7.67%2.06B | 181.42%2.82B | -118.49%-66M | 12.59%5.84B | 95.74%2.25B | 1,219.53%2.23B | -63.69%1B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -139.71%-166M | 58.51%894M | -167.92%-290M | 93.13%309M | 139.27%457M | 295.33%418M | 137.01%564M | 128.34%427M | 126.40%160M | 111.89%191M |
Net PPE purchase and sale | 52.57%-120M | 16.20%-812M | 20.82%-213M | 29.50%-141M | 13.14%-205M | 4.17%-253M | -27.84%-969M | -11.16%-269M | -29.87%-200M | -32.58%-236M |
Net investment purchase and sale | -106.85%-46M | 16.21%1.72B | -110.06%-71M | 27.56%449M | 31.05%671M | 855.06%672M | 298.26%1.48B | 72.62%706M | 192.63%352M | 137.67%512M |
Net other investing changes | ---- | -128.85%-15M | 40.00%-6M | -87.50%1M | 89.41%-9M | -100.72%-1M | 373.68%52M | -150.00%-10M | 111.11%8M | -23.19%-85M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -139.71%-166M | 58.51%894M | -167.92%-290M | 93.13%309M | 139.27%457M | 295.33%418M | 137.01%564M | 128.34%427M | 126.40%160M | 111.89%191M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -1.44%-1.62B | 20.93%-5.89B | 34.89%-1.42B | 32.29%-1.32B | 19.04%-1.55B | -13.89%-1.6B | -53.99%-7.45B | -58.04%-2.18B | -20.81%-1.95B | -73.80%-1.92B |
Net issuance payments of debt | --6M | --0 | --0 | --0 | --0 | --0 | -3,460.00%-504M | -4,718.18%-508M | 177.78%7M | ---2M |
Net common stock issuance | -4.50%-1.18B | 22.45%-4.25B | 24.87%-1.04B | 43.07%-883M | 23.55%-1.2B | -15.26%-1.13B | -36.52%-5.48B | -26.40%-1.38B | -29.25%-1.55B | -61.38%-1.57B |
Cash dividends paid | -6.49%-558M | -7.80%-2.17B | -6.87%-560M | -6.44%-562M | -8.96%-523M | -9.17%-524M | -9.53%-2.01B | -8.94%-524M | -9.32%-528M | -9.59%-480M |
Proceeds from stock option exercised by employees | 32.32%131M | 2.46%667M | -20.17%190M | -1.96%150M | 28.09%228M | 20.73%99M | -43.44%651M | 23.96%238M | 35.40%153M | -52.28%178M |
Net other financing activities | 58.54%-17M | -33.33%-136M | -75.00%-14M | 15.38%-22M | -28.26%-59M | -86.36%-41M | 32.45%-102M | 27.27%-8M | 16.13%-26M | 31.34%-46M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -1.44%-1.62B | 20.93%-5.89B | 34.89%-1.42B | 32.29%-1.32B | 19.04%-1.55B | -13.89%-1.6B | -53.99%-7.45B | -58.04%-2.18B | -20.81%-1.95B | -73.80%-1.92B |
Net cash flow | ||||||||||
Beginning cash position | 32.51%9.86B | -13.21%7.44B | 28.83%8.96B | 22.02%7.92B | -14.50%6.18B | -13.21%7.44B | -13.30%8.57B | -20.09%6.96B | -39.63%6.49B | -32.59%7.23B |
Current changes in cash | -11.79%-1.39B | 333.69%2.44B | 82.16%909M | 136.18%1.05B | 337.52%1.72B | 1.11%-1.25B | 11.09%-1.04B | 1,288.10%499M | 121.74%445M | -1,610.42%-725M |
Effect of exchange rate changes | 218.75%19M | 82.42%-16M | 30.77%-9M | -150.00%-10M | 272.73%19M | 81.61%-16M | 36.36%-91M | 85.23%-13M | --20M | 35.29%-11M |
End cash Position | 37.34%8.49B | 32.51%9.86B | 32.51%9.86B | 28.83%8.96B | 22.02%7.92B | -14.50%6.18B | -13.21%7.44B | -13.21%7.44B | -20.09%6.96B | -39.63%6.49B |
Free cash from | 185.89%274M | 35.82%6.62B | 21.27%2.41B | -5.52%1.92B | 241.44%2.61B | -443.01%-319M | 9.98%4.87B | 118.26%1.98B | 13,433.33%2.03B | -70.34%765M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.